Welcome to our dedicated page for Blade Air Mobility news (Ticker: BLDE), a resource for investors and traders seeking the latest updates and insights on Blade Air Mobility stock.
The BLDE news page on Stock Titan aggregates historical and transitional news for Blade Air Mobility, Inc., a technology-powered air mobility platform that has changed its corporate name to Strata Critical Medical, Inc. Company press releases describe Blade as providing air transportation and logistics for hospitals across the United States, where it is one of the largest transporters of human organs for transplant, and arranging passenger flights using helicopters and fixed-wing aircraft in the Northeast United States, Southern Europe and Western Canada.
News items for BLDE cover several key themes. Investors can review announcements about financial results, such as quarterly earnings releases furnished on Form 8-K, which discuss revenue trends, segment performance in Medical and Passenger operations, and non-GAAP metrics like Adjusted EBITDA and Flight Profit. Other articles highlight strategic transactions, including the agreement to sell Blade’s Passenger division to Joby Aviation and the subsequent completion of that sale, as well as the company’s rebranding and name change to Strata Critical Medical, Inc. with a new Nasdaq ticker symbol.
Coverage also includes capital markets and conference participation, where Blade executives present at technology, eVTOL and advanced air mobility events hosted by firms such as Oppenheimer, Jefferies, Ladenburg Thalmann and J.P. Morgan. Additional news features advanced air mobility milestones, such as Blade’s participation in an electric passenger flight using BETA Technologies’ ALIA CTOL aircraft, underscoring the company’s focus on quiet, emission-free air mobility.
By following BLDE news, readers can trace the evolution from a combined passenger and medical air mobility platform to a focused medical logistics business under the Strata Critical Medical name, and monitor how strategic partnerships, regulatory filings and operational updates have shaped that transition.
Blade Air Mobility (NASDAQ:BLDE) announced its upcoming name change to Strata Critical Medical, Inc., effective August 28, 2025. This rebranding reflects the company's strategic shift to focus on mission critical logistics and medical services for healthcare providers, following the sale of its Passenger business to Joby Aviation (NYSE:JOBY).
Starting August 29, 2025, the company will trade under the new ticker symbol "SRTA" on the Nasdaq Capital Market, with its warrants trading as "SRTAW". The CUSIP numbers will remain unchanged, and no action is required from securityholders.
Blade Air Mobility (NASDAQ:BLDE), a technology-powered air mobility platform, has announced its participation in the upcoming Oppenheimer 28th Annual Technology, Internet & Communications Conference. Will Heyburn, the company's Chief Financial Officer, will deliver a presentation on Monday, August 11, 2025 at 2:55pm ET.
Investors can access the presentation through a webcast, with a replay available afterward on the company's investor relations website at ir.blade.com/news-events.
Blade Air Mobility (NASDAQ:BLDE) announced Q2 2025 results and a major strategic transformation. The company will sell its Passenger division to Joby Aviation for up to $125 million, while its Medical division will remain a standalone public company rebranded as Strata Critical Medical.
Q2 2025 highlights include total revenue growth of 4.2% to $70.8 million, with Medical revenue increasing 17.6% to $45.1 million. Net loss improved by $7.6 million to $(3.7) million, and Adjusted EBITDA increased by $2.2 million to $3.2 million. The company ended Q2 with $113.4 million in cash and short-term investments.
Post-divestiture, Strata will operate as a pure-play healthcare solutions business, maintaining access to Joby's eVTOLs for medical use through a long-term partnership. The transaction is expected to be Adjusted EBITDA and Free Cash Flow neutral.
Blade Air Mobility (NASDAQ:BLDE) has announced the sale of its passenger division to Joby Aviation (NYSE:JOBY) for up to $125 million. Following the transaction, Blade will rebrand as Strata Critical Medical, focusing exclusively on medical logistics and services through its Trinity Medical Solutions subsidiary.
The deal includes Blade's US and European passenger operations, lounges, terminals, and brand rights. Post-transaction, Strata will maintain access to Joby's eVTOL aircraft for medical flights through a long-term partnership. The divestiture is expected to be Adjusted EBITDA and Free Cash Flow neutral, with $7 million in annual corporate cost efficiencies.
Leadership changes include current CEO Rob Wiesenthal joining Joby as Blade Air Mobility CEO, while Will Heyburn and Melissa Tomkiel will become Co-CEOs of Strata. The medical division represented 84% of 2024 Segment Adjusted EBITDA and 59% of Revenue.
Joby Aviation (NYSE:JOBY) has announced a strategic acquisition of Blade Air Mobility's passenger business for up to $125 million. The deal provides Joby with immediate access to Blade's extensive urban air mobility infrastructure, including 12 urban terminals across key markets in the U.S. and Europe.
The acquisition includes Blade's entire passenger operations, brand, and network of terminals, notably in New York City with locations at JFK, Newark, Manhattan's West and East sides, and Wall Street. Blade's Medical division will remain separate but partner with Joby for medical transportation. Blade's CEO Rob Wiesenthal will continue leading the passenger business as a Joby subsidiary.
This strategic move positions Joby for its commercial launch in Dubai next year and supports its global rollout plans. The company will leverage Blade's existing infrastructure and 50,000+ passenger base from 2024 to accelerate its transition from conventional helicopters to electric air taxis.
Blade Air Mobility (NASDAQ:BLDE) has scheduled its second quarter 2025 earnings conference call for Tuesday, August 5, 2025, at 8:00 am Eastern Time, following the release of financial results before market opens.
The conference call will feature CEO Rob Wiesenthal and CFO Will Heyburn, including a Q&A session. Interested participants can register to receive dial-in details and a unique PIN. The company will also provide an audio webcast accessible through their investor relations website, with a replay available for one year.
Blade Air Mobility (NASDAQ: BLDE), a technology-powered air mobility platform, has announced that CEO Rob Wiesenthal will deliver a presentation at the upcoming Ladenburg Thalmann Technology Innovation Expo 25. The presentation is scheduled for Wednesday, May 21, 2025, at 3:00 PM ET. Interested parties can access the presentation through a webcast, and a replay will be made available on the company's investor relations website at ir.blade.com/news-events shortly after the event concludes.
Blade Air Mobility (NASDAQ: BLDE), a technology-powered air mobility platform, has announced its participation in the 2025 J.P. Morgan Annual Global Technology, Media, and Communications Conference. Mat Schneider, Vice President of Investor Relations and Strategic Finance, will deliver a presentation on Wednesday, May 14, 2025, at 3:40 PM ET. The presentation will be accessible via webcast, with a replay available afterward on the company's investor relations website at ir.blade.com/news-events.